Delivery Order SPE2DB20D2104-SPE2DB25FMSEC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Fenofibrate 150 mg capsules (90-count units) with a ceiling value of $20,355.54. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,856.42 for Fenofibrate 40 mg tablets (90-count supply) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fenofibrate 120 mg tablets (90-count package) under a firm fixed-price contract with a ceiling value of $2,373.85. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Fenofibrate 120 mg tablets (90-count units) with a ceiling value of $26,126.95. The contract employs firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $24,832.85 to AmerisourceBergen Drug Corp for the supply of Fenofibrate 145 mg tablets (90-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $39,887.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fenofibrate 145 mg tablets (90-count supply) with an ultimate completion date of June 3, 2025. This non-set-aside award was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract relationship with the DLA....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.62 delivery order is for the supply of Fenofibrate 48 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,454.25 for 90 tablets of Fenofibrate 145 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,392.81 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Fenofibrate 145 mg tablets (90-count units). This non-set-aside, competitively awarded delivery order is scheduled for completion by September 10, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $552 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 160mg fenofibrate. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania. Performance of the firm fixed price order is required between August 11-14, 2023. No subcontractors or set aside designations were...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSECDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,396.17 to AmerisourceBergen Drug Corp for Fenofibric Acid DR 135 mg capsules (90-count supply) on June 2, 2025, with completion scheduled for June 3, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's substantial IDC with DLA Troop Support Medical enables comprehensive pharmaceutical distribution across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. The current delivery order for Fenofibric Acid represents routine pharmaceutical fulfillment under this established contract vehicle, reflecting the company's ongoing role as a primary pharmaceutical distributor for federal defense and military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/2/25 |